In animal models of cerebral ischemia, PPARγ activation by rosiglitazone also increases CD36 expression in microglia, which contributes to the resolution of inflammation and clearance of infiltrated neutrophils at 48 h following cerebral ischemia (Ballesteros et al., 2014). This evidence concerns the gene CD36 and brain ischemia.